IPRO is the Medicare Quality Improvement Organization for New York State.

Testimonials

Victoria Teodorescu, MD – Mount Sinai Vascular Surgeon. - "It gives me a great deal of satisfaction to work along with other highly-skilled clinicians dedicated to improving the health of fellow New Yorkers. We are already beginning to see an impact on the earlier detection and treatment of kidney disease through the efforts of members of the NY state CKD project."

Terry Tan – Program Coordinator – Janet & John Raggio Nephrology Institute @ LIJ North Shore Health System.  - “The IPRO CKD Project provides a forum for everyone working in the CKD field to brainstorm innovative ideas, exchange experiences, and most of all, inspire and encourage all of us to continuously combat CKD. It is always a shot in the arm when we are reminded that we are not fighting CKD on our own.”

Joseph Vassalotti, MD – Chief Medical Officer of National Kidney Foundation  - "I am delighted to participate in IPRO's Medicare quality improvement activities in early detection and management of CKD to improve outcomes for New Yorkers at risk. This exciting new dimension for the Medicare program expands focus beyond chronic kidney failure into earlier stages of disease, allowing more time for preventive interventions."

John P. Ward, MD – Primary Care Physician in Buffalo, NY  - “The CKD project has highlighted for us the continuum of kidney disease and given us tools and knowledge which will favorably impact this process for our patients. We understand that our role as primary care physicians affords us an opportunity to reduce the burden of renal disease on our patients and society as a whole.”

Carol LaFleur, Executive Director, National Kidney Foundation of Northeast New York  - “We appreciate being part of the CKD Coalition and applaud the efforts of IPRO in bringing together all of the stakeholders in an effort to slow the progression of kidney disease and implement clinical programs to improve treatment that will lead to better outcomes. Chronic kidney disease continues to be a major health problem and by bringing together our collective resources, we can improve lives for those affected and provide key resources to our clinical partners that can make their job of treating kidney patients, easier.”